Education
About Us
Working with TipRanks
Follow Us
Kingworld Medicines Group Ltd. (HK:1110)
:1110
Total Valuation
Kingworld Medicines Group Ltd. has a market cap or net worth of HK$327.51M. The enterprise value is HK$500.88M.
Market CapHK$327.51M
Enterprise ValueHK$500.88M
Share Statistics
Kingworld Medicines Group Ltd. has 622,499,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding622,499,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kingworld Medicines Group Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.92%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.92%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.11M
Profits Per Employee39.19K
Employee Count972
Asset Turnover0.81
Inventory Turnover6.78
Valuation Ratios
The current PE Ratio of Kingworld Medicines Group Ltd. is 9.15. Kingworld Medicines Group Ltd.’s PEG ratio is -0.89.
PE Ratio9.15
PS Ratio0.00
PB Ratio0.56
Price to Fair Value0.56
Price to FCF-5.51
Price to Operating Cash Flow8.24
PEG Ratio-0.89
Income Statement
In the last 12 months, Kingworld Medicines Group Ltd. had revenue of 1.08B and earned 38.10M in profits. Earnings per share was 0.06.
Revenue1.08B
Gross Profit280.67M
Operating Income96.81M
Pretax Income93.89M
Net Income38.10M
EBITDA125.48M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was 93.65M and capital expenditures -82.17M, giving a free cash flow of 11.48M billion.
Operating Cash Flow93.65M
Free Cash Flow11.48M
Free Cash Flow per Share0.02
Dividends & Yields
Kingworld Medicines Group Ltd. pays an annual dividend of HK$0.033, resulting in a dividend yield of 6.26%
Dividend Per ShareHK$0.033
Dividend Yield6.26%
Payout Ratio43.42%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change12.00%
50-Day Moving Average0.45
200-Day Moving Average0.48
Relative Strength Index (RSI)70.18
Average Volume (3m)1.60M
Important Dates
Kingworld Medicines Group Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 05, 2025
Financial Position
Kingworld Medicines Group Ltd. as a current ratio of 1.27, with Debt / Equity ratio of 58.72%
Current Ratio1.27
Quick Ratio1.02
Debt to Market Cap0.98
Net Debt to EBITDA1.44
Interest Coverage Ratio8.40
Taxes
In the past 12 months, Kingworld Medicines Group Ltd. has paid 32.29M in taxes.
Income Tax32.29M
Effective Tax Rate0.34
Enterprise Valuation
Kingworld Medicines Group Ltd. EV to EBITDA ratio is 4.22, with an EV/FCF ratio of -8.37.
EV to Sales0.49
EV to EBITDA4.22
EV to Free Cash Flow-8.37
EV to Operating Cash Flow12.52
Balance Sheet
Kingworld Medicines Group Ltd. has HK$302.10M in cash and marketable securities with ¥398.47M in debt, giving a net cash position of HK$86.32M billion.
Cash & Marketable SecuritiesHK$302.10M
Total Debt¥398.47M
Net CashHK$86.32M
Net Cash Per ShareHK$0.14
Tangible Book Value Per ShareHK$1.03
Margins
Gross margin is 25.03%, with operating margin of 8.97%, and net profit margin of 3.53%.
Gross Margin25.03%
Operating Margin8.97%
Pretax Margin8.70%
Net Profit Margin3.53%
EBITDA Margin11.63%
EBIT Margin9.77%
Analyst Forecast
The average price target for Kingworld Medicines Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.59%
EPS Growth Forecast4.81%